2023
DOI: 10.1371/journal.pgen.1010791
|View full text |Cite
|
Sign up to set email alerts
|

Mutators can drive the evolution of multi-resistance to antibiotics

Abstract: Antibiotic combination therapies are an approach used to counter the evolution of resistance; their purported benefit is they can stop the successive emergence of independent resistance mutations in the same genome. Here, we show that bacterial populations with ‘mutators’, organisms with defects in DNA repair, readily evolve resistance to combination antibiotic treatment when there is a delay in reaching inhibitory concentrations of antibiotic—under conditions where purely wild-type populations cannot. In popu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
3

Relationship

3
3

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 122 publications
(152 reference statements)
0
8
0
Order By: Relevance
“…This concentration of rifampicin was selected as we determined it to be the minimum inhibitory concentration (MIC) of the WT strain measured in MH. We used AUC as a measure of fitness as it is a well-used growth metric that integrates various features of the bacterial growth curve, such as growth rate and lag phase [ 29 32 ].
Figure 1 Investigating genotype-by-environment interactions of rpoB mutations.
…”
Section: Resultsmentioning
confidence: 99%
“…This concentration of rifampicin was selected as we determined it to be the minimum inhibitory concentration (MIC) of the WT strain measured in MH. We used AUC as a measure of fitness as it is a well-used growth metric that integrates various features of the bacterial growth curve, such as growth rate and lag phase [ 29 32 ].
Figure 1 Investigating genotype-by-environment interactions of rpoB mutations.
…”
Section: Resultsmentioning
confidence: 99%
“…Thus, some mutators could gain an additional advantage – over and above the effect of high mutation rate – if their mutation bias opposes that of the ancestor. Mutators are observed frequently in natural microbial populations as well as in clinical settings, where they are often associated with drug resistance [46,47]. Testing the impacts of mutation bias shifts on evolutionary dynamics is thus a promising direction for future research.…”
Section: Discussionmentioning
confidence: 99%
“…Mutation supply is a key evolutionary hurdle often limiting the adaptation of populations [ 1 , 65 67 ]. As mutation supply depends on population size, one might expect the supply of mutations, for instance to AMR, to be severely limited in small populations, such as the small number of cells forming an infectious propagule of E .…”
Section: Discussionmentioning
confidence: 99%
“…Uncovering the mechanisms behind environmentally responsive mutagenesis informs our understanding of evolution, notably antimicrobial resistance, where mutation supply can be critical [ 1 , 2 ]. Microbial mutation rates are responsive to a wide variety of environmental factors including population density [ 3 ], temperature [ 4 ], growth rate [ 5 , 6 ], stress [ 7 , 8 ], growth phase [ 9 ], and nutritional state [ 10 ].…”
Section: Introductionmentioning
confidence: 99%